Harmony Health Group Ltd 14630320 false 2023-02-01 2024-02-29 2024-02-29 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 14630320 2023-02-01 2024-02-29 14630320 2024-02-29 14630320 bus:Director1 1 2024-02-29 14630320 bus:OrdinaryShareClass1 2024-02-29 14630320 core:CurrentFinancialInstruments 2024-02-29 14630320 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 14630320 bus:SmallEntities 2023-02-01 2024-02-29 14630320 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-02-29 14630320 bus:FullAccounts 2023-02-01 2024-02-29 14630320 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-02-29 14630320 bus:RegisteredOffice 2023-02-01 2024-02-29 14630320 bus:Director1 2023-02-01 2024-02-29 14630320 bus:Director1 1 2023-02-01 2024-02-29 14630320 bus:OrdinaryShareClass1 2023-02-01 2024-02-29 14630320 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-02-29 14630320 countries:UnitedKingdom 2023-02-01 2024-02-29 14630320 bus:Director1 1 2023-01-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14630320

Harmony Health Group Ltd

Annual Report and Unaudited Financial Statements

for the Period from 1 February 2023 to 29 February 2024

 

Harmony Health Group Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 5

 

Harmony Health Group Ltd

(Registration number: 14630320)
Balance Sheet as at 29 February 2024

Note

2024
£

Current assets

 

Debtors

4

1,642

Cash at bank and in hand

 

645

 

2,287

Creditors: Amounts falling due within one year

5

(9,162)

Net liabilities

 

(6,875)

Capital and reserves

 

Called up share capital

6

1

Retained earnings

(6,876)

Shareholders' deficit

 

(6,875)

For the financial period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 21 October 2024
 

Dr A Davison
Director

   
     
 

Harmony Health Group Ltd

Notes to the Unaudited Financial Statements for the Period from 1 February 2023 to 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Parkhill Studio
Walton Road
Wetherby
West Yorkshire
LS22 5DZ
England

These financial statements were authorised for issue by the director on 21 October 2024.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Harmony Health Group Ltd

Notes to the Unaudited Financial Statements for the Period from 1 February 2023 to 29 February 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

4

Debtors

Current

2024
£

Trade debtors

245

Prepayments

1,397

 

1,642

 

Harmony Health Group Ltd

Notes to the Unaudited Financial Statements for the Period from 1 February 2023 to 29 February 2024

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

Due within one year

 

Loans and borrowings

7

8,333

Trade creditors

 

49

Accruals and deferred income

 

780

 

9,162

Creditors: amounts falling due after more than one year

2024
£

6

Share capital

Allotted, called up and fully paid shares

2024

No.

£

Ordinary shares of £1 each

1

1

   

7

Loans and borrowings

Current loans and borrowings

2024
£

Other borrowings

8,333

 

Harmony Health Group Ltd

Notes to the Unaudited Financial Statements for the Period from 1 February 2023 to 29 February 2024

8

Related party transactions

Transactions with the director

2024

At 1 February 2023
£

Advances to director
£

Other payments made to company by director
£

At 29 February 2024
£

Dr A Davison

Interest free loan

-

6,869

(15,202)

(8,333)

Director's remuneration

The director's remuneration for the period was as follows:

2024
£

Remuneration

8,341